Desafios na era pós genômica para o desenvolvimento de testes laboratoriais para o diagnóstico da hanseníase
Carregando...
Data
2008
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Leprosy diagnosis is based mainly on clinical manifestations and no laboratory test is available to diagnose asymptomatic disease or to predict disease progression among exposed individuals. Novel comparative genomic in silico analyses and molecular biology tools have discovered unique Mycobacterium leprae proteins with potential diagnostic application. Tuberculoid paucibacillary leprosy (PB) shows low antibodies titers and strong Th1 type/ IFN-γ specific cell mediated immunity (CMI), while lepromatous multibacillary patients (MB) show high antibody titers and low
CMI. Therefore, laboratory tests for PB and MB leprosy diagnosis will require CMI and antibody based assays. Serologically reactive recombinant Mycobacterium leprae proteins were identified and may be used in conjunction with PGL-I to improve MB patient diagnosis. Mycobacterium leprae recombinant proteins and synthetic peptides have been tested for CMI-interferon gamma based assays for PB diagnosis. Modified PGL-I serology incorporating new Mycobacterium leprae antigens and CMI tests based on IFN-γ γ production may permit the detection of leprosy PB and MB forms in endemic countries.
Descrição
Palavras-chave
Abordagem pós-genômica, Diagnóstico, Hanseníase, Post genomic approach, Diagnosis, Leprosy
Citação
STEFANI, Mariane Martins de Araújo. Desafios na era pós genômica para o desenvolvimento de testes laboratoriais para o diagnóstico da hanseníase. Revista da Sociedade Brasileira de Medicina Tropical, Uberaba, v. 41, p. 89-94, 2008.